Revance Therapeutics, Inc. (RVNC) stock price distance from twenty day simple moving average surged at 3.47% while its distance from fifty day simple moving average raised 0.15% along with 17.69% above distance from two hundred simple moving averages. On technical aspect, moving averages may help to distinguish path of dispositions, and they may also be used to set degrees of support and resistance.
Tracking the stock price in relation to moving averages as well as highs and lows for the year might assist with evaluating future stock performance.
The Stock has Weekly volatility of 4.85% and monthly volatility of 5.59%. Tracking most recent quarter period, Price to book (P/B) ration is at 3.82 and Price to cash per share ration is at 4.15. Beta value of the stock is marked at 1.35. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security’s price will be more volatile than the market. The company has a Return on Assets (ROA) of -56.00%. Presently, it has a Return on Equity (ROE) of -64.40% and Return on Investment (ROI) of -44.50%.
Revance Therapeutics, Inc. (RVNC) stock price tumbled -4.40% to finalize at $32.60 throughout previous buying and selling session. A total of 0.43 million shares exchanged at hands and its average trading volume is standing at 0.36 million shares. Important factors to focus when evaluating a stock’s present and future value are the 52 week price high and low levels. Shares of Revance Therapeutics, Inc. (RVNC) are trading -12.95% downward from the 52-week high mark and 81.11% above from the fifty two-week low mark.
Relative strength index (RSI-14) for Revance Therapeutics, Inc. (RVNC) is at 52.64. In phrases of Market analysis and buying and selling signals, RSI moving above the horizontal 30 reference standard is regarded as a bullish indicator, at the same time as the RSI transferring under the horizontal 70 reference standard is visible to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely moves underneath 30 notify oversold conditions.
Taking a glance at past performance, we will examine different up or down moving trends about RVNC. The stock added 3.66% beyond one week and climbed 7.95% during previous one month session. The stock went down -9.32% at some stage in past quarter. Inside the closing six months period the stock’s performance raised 32.79% while overall yearly performance gained 78.14%. The Company’s year to date (YTD) performance is now negative at -8.81%.
While taking a look at financials, we can look at a number of key indicators about Revance Therapeutics, Inc. (RVNC) . Average true range (ATR-14) of the company is at 1.
71. Developed by J. Welles Wilder, ATR is an indicator that measures volatility.
A stock experiencing a high level of volatility has a higher ATR, and a low volatility stock has a lower ATR. It may be used by market technicians to enter and exit trades, and it is a useful tool to add to a trading system.
The company’s quick ratio for most recent quarter is 13.60. Its Current ratio for most recent quarter of 13.60. Total debt to equity ratio of the company for most recent quarter is 0.01 while Long term debt to equity ratio for same time period is 0.00.
